Mengod G, Goudsmit E, Probst A, Palacios J M
Department of Neurochemistry, CID-CSIC, Barcelona, Spain.
Prog Brain Res. 1992;93:45-55. doi: 10.1016/s0079-6123(08)64562-8.
We have seen that mRNA for several neuropeptides can be visualized at the microscopic level in human post-mortem brain tissues using in situ hybridization histochemistry and oligonucleotides as probes. The specificity of the hybridization signal detected in each case is supported by several criteria such as Northern blot analysis, use of at least two oligonucleotides complementary to different regions of the same target mRNA, cohybridization of labeled and excess unlabeled oligonucleotide probes, and melting curve analysis of the formed hybrids. Furthermore, factors such as age, post-mortem delay or gender did not show a significant effect in the levels of hybridization in the control population studied. Hybridization signals comparable to those found in the control population were obtained in frozen tissues, stored for up to 6 years before analysis. The results obtained for the different neuropeptides examined are, in general, in good agreement with the available information on their distribution and cellular localization as determined by radioimmunoassay or immunohistochemistry. The use of in situ hybridization histochemistry has clearly revealed the location of neurons synthesizing these neuropeptides, adding important information to that provided by radioimmunoassay or immunohistochemistry. A typical example is the identification of peptide synthesizing neuronal cell bodies by immunohistochemistry. This requires, in some cases, the use of treatments such as colchicine, obviously impossible with human brain tissues. The abundance of mRNA could be further related to transcriptional activity and, when compared with peptide levels, can provide some clues on peptide turnover rates. Thus in the hypothalamus, the paraventricular and supraoptic nuclei were found to contain cells expressing arginine-vasopressin and oxytocin mRNAs. Their distribution was in good agreement with that determined by immunohistochemistry (Dierickx and Vandesande, 1977). We have also found that these nuclei contain transcripts for neuropeptide genes such as preproenkephalin A, neuropeptide Y and somatostatin, in agreement with previously reported immunohistochemical data (Agid and Javoy-Agid, 1985; Emson et al., 1986). In the basal ganglia, numerous cells heterogeneously distributed throughout the caudate and putamen nuclei were found to contain preproenkephalin A mRNA.(ABSTRACT TRUNCATED AT 400 WORDS)
我们已经看到,使用原位杂交组织化学和寡核苷酸作为探针,可以在显微镜水平上在人类尸检脑组织中可视化几种神经肽的信使核糖核酸(mRNA)。在每种情况下检测到的杂交信号的特异性都得到了几个标准的支持,如Northern印迹分析、使用至少两种与同一目标mRNA不同区域互补的寡核苷酸、标记的和过量未标记的寡核苷酸探针的共杂交以及形成的杂交体的熔解曲线分析。此外,年龄、尸检延迟或性别等因素在所研究的对照人群中并未对杂交水平产生显著影响。在冷冻组织中获得了与对照人群中发现的杂交信号相当的信号,这些组织在分析前保存了长达6年。对于所检测的不同神经肽获得的结果总体上与通过放射免疫测定或免疫组织化学确定的关于它们的分布和细胞定位的现有信息一致。原位杂交组织化学的使用清楚地揭示了合成这些神经肽的神经元的位置,为放射免疫测定或免疫组织化学提供的信息增添了重要内容。一个典型的例子是通过免疫组织化学鉴定肽合成神经元细胞体。在某些情况下,这需要使用诸如秋水仙碱的处理方法,而这对于人类脑组织显然是不可能的。mRNA的丰度可能进一步与转录活性相关,并且与肽水平相比,可以提供一些关于肽周转速率的线索。因此,在下丘脑中,发现室旁核和视上核含有表达精氨酸加压素和催产素mRNA的细胞。它们的分布与通过免疫组织化学确定的分布一致(迪里克克斯和万德桑德,1977年)。我们还发现这些核含有神经肽基因的转录本,如前脑啡肽原A、神经肽Y和生长抑素,这与先前报道的免疫组织化学数据一致(阿吉德和雅沃伊 - 阿吉德,1985年;埃姆森等人,1986年)。在基底神经节中,发现尾状核和壳核中大量异质性分布的细胞含有前脑啡肽原A mRNA。(摘要截于400字)